These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18692250)

  • 41. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Mann JJ
    Am J Psychiatry; 2007 Jul; 164(7):1044-9. PubMed ID: 17606656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
    Morrison J; Schwartz TL
    Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
    Brent DA; Emslie GJ; Clarke GN; Asarnow J; Spirito A; Ritz L; Vitiello B; Iyengar S; Birmaher B; Ryan ND; Zelazny J; Onorato M; Kennard B; Mayes TL; Debar LL; McCracken JT; Strober M; Suddath R; Leonard H; Porta G; Keller MB
    Am J Psychiatry; 2009 Apr; 166(4):418-26. PubMed ID: 19223438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FDA questions antidepressant safety for children.
    Oransky I
    Lancet; 2003 Nov; 362(9395):1558. PubMed ID: 14627000
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacotherapy of major depressive disorder in adolescents.
    Masi G; Liboni F; Brovedani P
    Expert Opin Pharmacother; 2010 Feb; 11(3):375-86. PubMed ID: 20102303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressants use in pediatric populations.
    Gören JL
    Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse events reported by anxious school refusing adolescents receiving cognitive behavioral therapy with and without fluoxetine.
    Melvin GA; Finnin L; Taffe J; Dudley AL; Klimkeit EI; Gordon MS; Tonge B
    Clin Child Psychol Psychiatry; 2019 Oct; 24(4):892-905. PubMed ID: 30638065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological treatment of children and adolescents with depression.
    Vitiello B; Ordóñez AE
    Expert Opin Pharmacother; 2016 Dec; 17(17):2273-2279. PubMed ID: 27690663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Medical treatment of depression in children and adolescents].
    Kölch M; Fegert JM
    Prax Kinderpsychol Kinderpsychiatr; 2007; 56(3):224-33. PubMed ID: 17451152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Erkens JA; Herings RM; Mann JJ
    Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
    Atkinson SD; Prakash A; Zhang Q; Pangallo BA; Bangs ME; Emslie GJ; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):180-9. PubMed ID: 24813026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.
    Gibbons RD; Brown CH; Hur K; Davis J; Mann JJ
    Arch Gen Psychiatry; 2012 Jun; 69(6):580-7. PubMed ID: 22309973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Poor response to antidepressants predicts new suicidal ideas and behavior in depressed outpatients.
    Courtet P; Jaussent I; Lopez-Castroman J; Gorwood P
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1650-8. PubMed ID: 25112546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
    Emslie GJ; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):170-9. PubMed ID: 24815533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
    Perroud N; Uher R; Marusic A; Rietschel M; Mors O; Henigsberg N; Hauser J; Maier W; Souery D; Placentino A; Szczepankiewicz A; Jorgensen L; Strohmaier J; Zobel A; Giovannini C; Elkin A; Gunasinghe C; Gray J; Campbell D; Gupta B; Farmer AE; McGuffin P; Aitchison KJ
    BMC Med; 2009 Oct; 7():60. PubMed ID: 19832967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychopharmacology. Study questions antidepressant risks.
    Couzin J
    Science; 2007 Apr; 316(5823):354. PubMed ID: 17446361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.